FEBBO PHILLIP G. (Chief Scientific & Med Officer) sold 10.3% of their position (13.43K shares) of VERACYTE, INC. on the open market
Open‑market sale worth $485.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/4/2026ACC: 0001649245-26-000004
Officer· Chief Scientific & Med Officer
Since Mar 2026
-19.46K
Net shares
Net seller
$702.7K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
19.46K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−6.04K
Price / share
$36.01
Trade value
$217.32K
% of position
4.4%
3/2/2026
136.81K→130.77K
Common Stock
Direct
Shares
−13.43K
Price / share
$36.16
Trade value
$485.43K
% of position
10.3%
3/2/2026
130.77K→117.35K
Total
Net shares
−19.46K
Net value
-$702.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | F · Tax Withholding | −6.04K | $36.01 | $217.32K | 4.4% | 136.81K | 130.77K |
| Common Stock Direct | 3/2/2026 | S · Sale | −13.43K | $36.16 | $485.43K | 10.3% | 130.77K | 117.35K |
| Total | −19.46K | -$702.75K | ||||||
Derivative Transactions0
No derivative transactions reported